{"filing":{"accession_number":"0001606757-26-000028","cik":"0001606757","ticker":"KE","company_name":"Kimball Electronics, Inc.","form":"8-K","filing_date":"2026-07-01","report_date":null,"primary_document":"ke-20260626.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1606757/000160675726000028/ke-20260626.htm"},"events":[{"id":15271,"run_id":13627,"accession_number":"0001606757-26-000028","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"Kimball Electronics completed the acquisition of Helvoet Polymer Technologies B.V. and related entities for approximately €90 million ($103 million) on June 26–July 1, 2026. The transaction expands Kimball's medical CDMO platform globally and is expected to be accretive to fiscal 2027 adjusted earnings.","company_name":"Kimball Electronics, Inc.","ticker":"KE","filing_date":"2026-07-01","form":"8-K","submitted_at":null,"items":[{"id":12966,"accession_number":"0001606757-26-000028","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Kimball Electronics entered into and completed a material acquisition of Helvoet Polymer Technologies B.V. and related entities for approximately €90 million ($103 million) on June 26–July 1, 2026. The filing explicitly discloses entry into a definitive agreement (Item 1.01) and the transaction's closure, with the purchase price, funding sources, and strategic rationale clearly articulated. The supplemental press release confirms this is a significant strategic acquisition expected to be accretive to fiscal 2027 earnings and expand Kimball's medical CDMO platform globally.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T11:36:16.003934+00:00","company_name":"","ticker":null,"filing_date":""},{"id":12967,"accession_number":"0001606757-26-000028","item_number":"7.01","item_title":"Regulation FD","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Kimball Electronics announced the completion of its acquisition of Helvoet Polymer Technologies B.V., a European-based medical CDMO, for approximately €90 million ($103 million). The transaction is valued at approximately 9x estimated adjusted EBITDA and is expected to be accretive to fiscal 2027 adjusted earnings, representing a material acquisition that expands Kimball's global medical CMO platform and manufacturing footprint in Europe and India. This is a completed material acquisition disclosed under Item 7.01 (Regulation FD Disclosure).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T11:36:16.003934+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12966,"accession_number":"0001606757-26-000028","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Kimball Electronics entered into and completed a material acquisition of Helvoet Polymer Technologies B.V. and related entities for approximately €90 million ($103 million) on June 26–July 1, 2026. The filing explicitly discloses entry into a definitive agreement (Item 1.01) and the transaction's closure, with the purchase price, funding sources, and strategic rationale clearly articulated. The supplemental press release confirms this is a significant strategic acquisition expected to be accretive to fiscal 2027 earnings and expand Kimball's medical CDMO platform globally.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T11:36:16.003934+00:00","company_name":"Kimball Electronics, Inc.","ticker":"KE","filing_date":"2026-07-01"},{"id":12967,"accession_number":"0001606757-26-000028","item_number":"7.01","item_title":"Regulation FD","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Kimball Electronics announced the completion of its acquisition of Helvoet Polymer Technologies B.V., a European-based medical CDMO, for approximately €90 million ($103 million). The transaction is valued at approximately 9x estimated adjusted EBITDA and is expected to be accretive to fiscal 2027 adjusted earnings, representing a material acquisition that expands Kimball's global medical CMO platform and manufacturing footprint in Europe and India. This is a completed material acquisition disclosed under Item 7.01 (Regulation FD Disclosure).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T11:36:16.003934+00:00","company_name":"Kimball Electronics, Inc.","ticker":"KE","filing_date":"2026-07-01"}]}